Genome-wide transcriptional profiling reveals that HIV-1 Vpr differentially regulates interferon-stimulated genes in human monocyte-derived dendritic cells

Virus Research

Volumn 208, Issue , 2015, Pages 156-163

  Zahoor, Muhammad Atif ^a,b   Xue, Guangai ^a,b,c   Sato, Hirotaka ^a   Aida, Yoko ^a  

^a RIKEN   (Japan)

^b JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

^c Japanese Foundation of AIDS Prevention   (Japan)

Author keywords

HIV 1 Vpr; Immune response; Interferon stimulation genes (ISGs); Microarray; Monocyte derived dendritic cells; Recombinant adenoviral vector; Type I interferon

Indexed keywords

INTERFERON; VPR PROTEIN; INTERFERON REGULATORY FACTOR; VPR PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IFI27 GENE; IFI44L GENE; IFIT1 GENE; IFIT2 GENE; IFIT3 GENE; INNATE IMMUNITY; ISG15 GENE; ISG20 GENE; MICROARRAY ANALYSIS; MONOCYTE DERIVED DENDRITIC CELL; MX2 GENE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TNFSF10 GENE; VIRUS GENOME; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSCRIPTION; CYTOLOGY; GENETICS; HOST PATHOGEN INTERACTION; HUMAN GENOME; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; METABOLISM; MONOCYTE; VIROLOGY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

DENDRITIC CELLS; GENOME, HUMAN; HIV INFECTIONS; HIV-1; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTORS; MONOCYTES; VPR GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84938697715     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2015.06.017     Document Type: Article

References (64)

1. Aida Y., Matsuda G. Role of Vpr in HIV-1 nuclear import: therapeutic implications. Curr. HIV Res. 2009, 7(2):136-143.
2. Ayyavoo V., Mahboubi A., Mahalingam S., Ramalingam R., Kudchodkar S., Williams W.V., Green D.R., Weiner D.B. HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 1997, 3(10):1117-1123.
3. Banchereau J., Palucka A.K. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 2005, 5(4):296-306.
4. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature 1998, 392(6673):245-252.
5. Bender A., Sapp M., Schuler G., Steinman R.M., Bhardwaj N. Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J. Immunol. Methods 1996, 196(2):121-135.
6. Berger G., Durand S., Fargier G., Nguyen X.N., Cordeil S., Bouaziz S., Muriaux D., Darlix J.L., Cimarelli A. APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells. PLoS Pathog. 2011, 7(9):e1002221.
7. Blanco-Melo D., Venkatesh S., Bieniasz P.D. Intrinsic cellular defenses against human immunodeficiency viruses. Immunity 2012, 37(3):399-411.
8. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R., Stark G.R. Interferons at age 50: past, current and future impact on biomedicine. Nat. Rev. Drug Discov. 2007, 6(12):975-990.
9. Bovolenta C., Camorali L., Lorini A.L., Ghezzi S., Vicenzi E., Lazzarin A., Poli G. Constitutive activation of STATs upon in vivo human immunodeficiency virus infection. Blood 1999, 94(12):4202-4209.
10. Chaudhuri A., Yang B., Gendelman H.E., Persidsky Y., Kanmogne G.D. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 2008, 111(4):2062-2072.
11. Cohen E.A., Dehni G., Sodroski J.G., Haseltine W.A. Human immunodeficiency virus Vpr product is a virion-associated regulatory protein. J. Virol. 1990, 64(6):3097-3099.
12. Connor R.I., Chen B.K., Choe S., Landau N.R. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 1995, 206(2):935-944.
13. Darnell J.E. STATs and gene regulation. Science 1997, 277(5332):1630-1635.
14. de Noronha C.M., Sherman M.P., Lin H.W., Cavrois M.V., Moir R.D., Goldman R.D., Greene W.C. Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science 2001, 294(5544):1105-1108.
15. de Veer M.J., Holko M., Frevel M., Walker E., Der S., Paranjape J.M., Silverman R.H., Williams B.R. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 2001, 69(6):912-920.
16. Der S.D., Zhou A., Williams B.R., Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc. Natl. Acad. Sci. U. S. A. 1998, 95(26):15623-15628.
17. Espert L., Degols G., Lin Y.L., Vincent T., Benkirane M., Mechti N. Interferon-induced exonuclease ISG20 exhibits an antiviral activity against human immunodeficiency virus type 1. J. Gen. Virol. 2005, 86(Pt 8):2221-2229.
18. Granelli-Piperno A., Golebiowska A., Trumpfheller C., Siegal F.P., Steinman R.M. HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit IL-10 production and T cell regulation. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(20):7669-7674.
19. Haller O., Kochs G. Human MxA protein: an interferon-induced dynamin-like GTPase with broad antiviral activity. J. Interferon Cytokine Res. 2011, 31(1):79-87.
20. Hashizume C., Kuramitsu M., Zhang X., Kurosawa T., Kamata M., Aida Y. Human immunodeficiency virus type 1 Vpr interacts with spliceosomal protein SAP145 to mediate cellular pre-mRNA splicing inhibition. Microbes Infect. 2007, 9(4):490-497.
21. Heinzinger N.K., Bukrinsky M.I., Haggerty S.A., Ragland A.M., Kewalramani V., Lee M.A., Gendelman H.E., Ratner L., Stevenson M., Emerman M. The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. U. S. A. 1994, 91(15):7311-7315.
22. Herbeuval J.P., Boasso A., Grivel J.C., Hardy A.W., Anderson S.A., Dolan M.J., Chougnet C., Lifson J.D., Shearer G.M. TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected patients and its in vitro production by antigen-presenting cells. Blood 2005, 105(6):2458-2464.
23. Horvath C.M., Darnell J.E. The antiviral state induced by alpha interferon and gamma interferon requires transcriptionally active Stat1 protein. J. Virol. 1996, 70(1):647-650.
24. Huang Y., Walstrom A., Zhang L., Zhao Y., Cui M., Ye L., Zheng J.C. Type I interferons and interferon regulatory factors regulate TNF-related apoptosis-inducing ligand (TRAIL) in HIV-1-infected macrophages. PLoS ONE 2009, 4(4):e5397.
25. Jeremias I., Herr I., Boehler T., Debatin K.M. TRAIL/Apo-2-ligand-induced apoptosis in human T cells. Eur. J. Immunol. 1998, 28(1):143-152.
26. Jowett J.B., Planelles V., Poon B., Shah N.P., Chen M.L., Chen I.S. The human immunodeficiency virus type 1 Vpr gene arrests infected T cells in the G2+M phase of the cell cycle. J. Virol. 1995, 69(10):6304-6313.
27. Kamata M., Nitahara-Kasahara Y., Miyamoto Y., Yoneda Y., Aida Y. Importin-alpha promotes passage through the nuclear pore complex of human immunodeficiency virus type 1 Vpr. J. Virol. 2005, 79(6):3557-3564.
28. Kane M., Yadav S.S., Bitzegeio J., Kutluay S.B., Zang T., Wilson S.J., Schoggins J.W., Rice C.M., Yamashita M., Hatziioannou T., Bieniasz P.D. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 2013, 502(7472):563-566.
29. Kino T., Gragerov A., Slobodskaya O., Tsopanomichalou M., Chrousos G.P., Pavlakis G.N. Human immunodeficiency virus type 1 (HIV-1) accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. J. Virol. 2002, 76(19):9724-9734.
30. Kuramitsu M., Hashizume C., Yamamoto N., Azuma A., Kamata M., Yamamoto N., Tanaka Y., Aida Y. A novel role for Vpr of human immunodeficiency virus type 1 as a regulator of the splicing of cellular pre-mRNA. Microbes Infect. 2005, 7(9-10):1150-1160.
31. Laguette N., Sobhian B., Casartelli N., Ringeard M., Chable-Bessia C., Segeral E., Yatim A., Emiliani S., Schwartz O., Benkirane M. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 2011, 474(7353):654-657.
32. Laguette N., Bregnard C., Hue P., Basbous J., Yatim A., Larroque M., Kirchhoff F., Constantinou A., Sobhian B., Benkirane M. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 2014, 156(1-2):134-145.
33. Levy D.N., Fernandes L.S., Williams W.V., Weiner D.B. Induction of cell differentiation by human immunodeficiency virus 1 Vpr. Cell 1993, 72(4):541-550.
34. Liabakk N.B., Sundan A., Torp S., Aukrust P., Froland S.S., Espevik T. Development, characterization and use of monoclonal antibodies against sTRAIL: measurement of sTRAIL by ELISA. J. Immunol. Methods 2002, 259(1-2):119-128.
35. Mashiba M., Collins D.R., Terry V.H., Collins K.L. Vpr overcomes macrophage-specific restriction of HIV-1 Env expression and virion production. Cell Host Microbe 2014, 16(6):722-735.
36. Murakami T., Aida Y. Visualizing Vpr-induced g2 arrest and apoptosis. PLOS ONE 2014, 9(1):e86840.
37. Muthumani K., Hwang D.S., Choo A.Y., Mayilvahanan S., Dayes N.S., Thieu K.P., Weiner D.B. HIV-1 Vpr inhibits the maturation and activation of macrophages and dendritic cells in vitro. Int. Immunol. 2005, 17(2):103-116.
38. Nasr N., Maddocks S., Turville S.G., Harman A.N., Woolger N., Helbig K.J., Wilkinson J., Bye C.R., Wright T.K., Rambukwelle D., Donaghy H., Beard M.R., Cunningham A.L. HIV-1 infection of human macrophages directly induces viperin which inhibits viral production. Blood 2012, 120(4):778-788.
39. Neil S., Bieniasz P. Human immunodeficiency virus, restriction factors, and interferon. J. Interferon Cytokine Res. 2009, 29(9):569-580.
40. Nishizawa M., Kamata M., Mojin T., Nakai Y., Aida Y. Induction of apoptosis by the Vpr protein of human immunodeficiency virus type 1 occurs independently of G(2) arrest of the cell cycle. Virology 2000, 276(1):16-26.
41. Nitahara-Kasahara Y., Kamata M., Yamamoto T., Zhang X., Miyamoto Y., Muneta K., Iijima S., Yoneda Y., Tsunetsugu-Yokota Y., Aida Y. Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages. J. Virol. 2007, 81(10):5284-5293.
42. Okumura A., Lu G., Pitha-Rowe I., Pitha P.M. Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc. Natl. Acad. Sci. U. S. A. 2006, 103(5):1440-1445.
43. Pichlmair A., Lassnig C., Eberle C.A., Gorna M.W., Baumann C.L., Burkard T.R., Burckstummer T., Stefanovic A., Krieger S., Bennett K.L., Rulicke T., Weber F., Colinge J., Muller M., Superti-Furga G. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nat. Immunol. 2011, 12(7):624-630.
44. Pincetic A., Kuang Z., Seo E.J., Leis J. The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. J. Virol. 2010, 84(9):4725-4736.
45. Pion M., Granelli-Piperno A., Mangeat B., Stalder R., Correa R., Steinman R.M., Piguet V. APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection. J. Exp. Med. 2006, 203(13):2887-2893.
46. Poon B., Grovit-Ferbas K., Stewart S.A., Chen I.S. Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents. Science 1998, 281(5374):266-269.
47. Popov S., Rexach M., Zybarth G., Reiling N., Lee M.A., Ratner L., Lane C.M., Moore M.S., Blobel G., Bukrinsky M. Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 1998, 17(4):909-917.
48. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89(Pt 1):1-47.
49. Sabado R.L., O'Brien M., Subedi A., Qin L., Hu N., Taylor E., Dibben O., Stacey A., Fellay J., Shianna K.V., Siegal F., Shodell M., Shah K., Larsson M., Lifson J., Nadas A., Marmor M., Hutt R., Margolis D., Garmon D., Markowitz M., Valentine F., Borrow P., Bhardwaj N. Evidence of dysregulation of dendritic cells in primary HIV infection. Blood 2010, 116(19):3839-3852.
50. Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008, 8(7):559-568.
51. Saitoh T., Satoh T., Yamamoto N., Uematsu S., Takeuchi O., Kawai T., Akira S. Antiviral protein Viperin promotes Toll-like receptor 7- and Toll-like receptor 9-mediated type I interferon production in plasmacytoid dendritic cells. Immunity 2011, 34(3):352-363.
52. Samuel C.E. Antiviral actions of interferons. Clin. Microbiol. Rev. 2001, 14(4):778-809. table of contents.
53. Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 2011, 1(6):519-525.
54. Schoggins J.W., Wilson S.J., Panis M., Murphy M.Y., Jones C.T., Bieniasz P., Rice C.M. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 2011, 472(7344):481-485.
55. Skaug B., Chen Z.J. Emerging role of ISG15 in antiviral immunity. Cell 2011, 143(2):187-190.
56. Takeda E., Murakami T., Matsuda G., Murakami H., Zako T., Maeda M., Aida Y. Nuclear exportin receptor CAS regulates the NPI-1-mediated nuclear import of HIV-1 Vpr. PLoS ONE 2011, 6(11):e27815.
57. Varin A., Decrion A.Z., Sabbah E., Quivy V., Sire J., Van Lint C., Roques B.P., Aggarwal B.B., Herbein G. Synthetic Vpr protein activates activator protein-1, c-Jun N-terminal kinase, and NF-kappaB and stimulates HIV-1 transcription in promonocytic cells and primary macrophages. J. Biol. Chem. 2005, 280(52):42557-42567.
58. Wahren B., Morfeldt-Mansson L., Biberfeld G., Moberg L., Sonnerborg A., Ljungman P., Werner A., Kurth R., Gallo R., Bolognesi D. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection. J. Virol. 1987, 61(6):2017-2023.
59. Wu L., KewalRamani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 2006, 6(11):859-868.
60. Yang Y., Tikhonov I., Ruckwardt T.J., Djavani M., Zapata J.C., Pauza C.D., Salvato M.S. Monocytes treated with human immunodeficiency virus Tat kill uninfected CD4(+) cells by a tumor necrosis factor-related apoptosis-induced ligand-mediated mechanism. J. Virol. 2003, 77(12):6700-6708.
61. Zahoor M.A., Xue G., Sato H., Murakami T., Takeshima S.N., Aida Y. HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages. PLOS ONE 2014, 9(8):e106418.
62. Zhang D., Zhang D.E. Interferon-stimulated gene 15 and the protein ISGylation system. J. Interferon Cytokine Res. 2011, 31(1):119-130.
63. Zhou L.J., Tedder T.F. CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(6):2588-2592.
64. Zhou Z., Wang N., Woodson S.E., Dong Q., Wang J., Liang Y., Rijnbrand R., Wei L., Nichols J.E., Guo J.T., Holbrook M.R., Lemon S.M., Li K. Antiviral activities of ISG20 in positive-strand RNA virus infections. Virology 2011, 409(2):175-188.